Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 65 | 44 | −21 |
| Shares | 19.0M | 5.23M | −13.7M (−72.4%) |
| Value | $40.8M | $1.20M | −$39.6M (−97.1%) |
New holders (8)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 150,000 | $34.5K | 0.01% |
| Two Sigma Securities, LLC | 107,742 | $24.8K | 0.00% |
| HRT Financial LP | 87,535 | $20.0K | 0.00% |
| Jane Street Group, LLC | 52,920 | $12.2K | 0.00% |
| Baader Bank INC | 22,092 | $4.54K | 0.00% |
| FNY Investment Advisers, LLC | 5,100 | $1.00K | 0.00% |
| SBI Securities Co., Ltd. | 1,883 | $433 | 0.00% |
| Truvestments Capital LLC | 10 | $2 | 0.00% |
Sold out (29)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.